For example, previous authors have demonstrated the capabilities of miRNAs to predict breast cancer hormone receptor status, others have evaluated the role of miRNAs as therapeutic options in cancer [19,20,21,22], and several previous reports have correlated miRNA expression profiles with long-term survival outcomes in malignancy [23,24,25]. The gene discussed is NR4A1; the disease is breast carcinoma.